Form 4: Dayforce Inc. President and COO Stephen Holdridge Sells 1,000 Shares
SEC Form 4 Filing
Stephen H. Holdridge, President and COO of Dayforce Inc., sold 1,000 shares of common stock at $63.37 per share on October 15, 2024, according to a Form 4 filing with the SEC.
Summary
- On October 15, 2024, Stephen H. Holdridge, the President and COO of Dayforce Inc., sold 1,000 shares of the company's common stock at a price of $63.37 per share.
- The transaction was executed under a Rule 10b5-1 trading plan adopted on May 7, 2024.
- Following the transaction, Holdridge directly owns 101,437 shares of Dayforce Inc.
- This includes holdings of common stock, restricted stock units (RSUs), and performance stock units (PSUs).
- Holdridge also holds options to buy 65,547 shares at an exercise price of $70.73, which are fully vested and exercisable.
- The filing also details Holdridge's holdings of various performance units (PSUs) that will vest based on the achievement of certain performance metrics, with potential vesting dates ranging from February 2025 to March 2027.
- The number of shares ultimately issued for PSUs can range from 0% to 200% of the target number, depending on performance.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was conducted under a pre-arranged trading plan and doesn't necessarily reflect a change in the insider's view of the company's prospects.
Future Outlook
The vesting of restricted stock units and performance stock units is contingent upon continued employment and the achievement of performance metrics, respectively.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, although the pre-planned nature of the sale mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 05/07/2024 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| 10/15/2024 | Date of the transaction (sale of common stock) |
| 10/17/2024 | Date of signature on the Form 4 filing |
| 02/24/2025 | Vesting date for 7,059 shares of Common Stock issuable pursuant to restricted stock units (RSU) |
| 02/28/2025 | Vesting date for 9,141 shares of Common Stock issuable pursuant to RSUs |
| 03/01/2025 | Vesting date for 12,210 shares of Common Stock issuable pursuant to RSUs |
| 02/28/2026 | Vesting date for 9,141 shares of Common Stock issuable pursuant to RSUs |
| 03/01/2026 | Vesting date for 12,210 shares of Common Stock issuable pursuant to RSUs |
| 03/01/2027 | Vesting date for 12,210 shares of Common Stock issuable pursuant to RSUs |
| 02/28/2030 | Expiration date for options (right to buy) Common Stock |
| 02/24/2032 | Expiration date for Performance Units |
| 02/28/2033 | Expiration date for Performance Units |
| 03/01/2034 | Expiration date for Performance Units |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.